null

SMILES: CC(C)(C)C(=O)N1CCC[C@H](C1)C(=O)N[C@@H](CCN1CC[C@@H](CCc2ccc3CCCNc3n2)C1)C(O)=O

InChI Key: InChIKey=YCMSWZZCSCNHJZ-BKULYWANSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 448847   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Integrin alpha-V/beta-6 (Homo sapiens (Human))	BDBM448847 (US10696672, Compound 79 | US11634418, Compound 79) Show SMILES CC(C)(C)C(=O)N1CCC[C@H](C1)C(=O)N[C@@H](CCN1CC[C@@H](CCc2ccc3CCCNc3n2)C1)C(O)=O |r| Show InChI InChI=1S/C29H45N5O4/c1-29(2,3)28(38)34-15-5-7-22(19-34)26(35)32-24(27(36)37)13-17-33-16-12-20(18-33)8-10-23-11-9-21-6-4-14-30-25(21)31-23/h9,11,20,22,24H,4-8,10,12-19H2,1-3H3,(H,30,31)(H,32,35)(H,36,37)/t20-,22-,24+/m1/s1	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem		n/a	n/a	<50	n/a	n/a	n/a	n/a	n/a	n/a
TBA									Citation and Details BindingDB Entry DOI: 10.7270/Q22J6GS4
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-6 (Homo sapiens (Human))	BDBM448847 (US10696672, Compound 79 | US11634418, Compound 79) Show SMILES CC(C)(C)C(=O)N1CCC[C@H](C1)C(=O)N[C@@H](CCN1CC[C@@H](CCc2ccc3CCCNc3n2)C1)C(O)=O |r| Show InChI InChI=1S/C29H45N5O4/c1-29(2,3)28(38)34-15-5-7-22(19-34)26(35)32-24(27(36)37)13-17-33-16-12-20(18-33)8-10-23-11-9-21-6-4-14-30-25(21)31-23/h9,11,20,22,24H,4-8,10,12-19H2,1-3H3,(H,30,31)(H,32,35)(H,36,37)/t20-,22-,24+/m1/s1	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<50	n/a	n/a	n/a	n/a	n/a	n/a
Pliant Therapeutics, Inc. US Patent					Assay Description Microplates were coated with recombinant human integrin αvβ6 (2 ug/ml) in PBS (100 ul/well 25° C., overnight). The coating solution was rem...				US Patent US10696672 (2020) BindingDB Entry DOI: 10.7270/Q2TT4V06
					More data for this Ligand-Target Pair